LC
CTSO icon

Lindbrook Capital’s Cytosorbents Corp CTSO Stock Holding History

Lindbrook Capital’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-125
Closed -$1K – 2094
2021
Q3 		$1K Hold
125
– – ﹤0.01% 1691
2021
Q2 		$1K Hold
125
– – ﹤0.01% 1733
2021
Q1 		$1K Hold
125
– – ﹤0.01% 1692
2020
Q4 		$1K Hold
125
– – ﹤0.01% 1593
2020
Q3 		$1K Hold
125
– – ﹤0.01% 1531
2020
Q2 		$1K Hold
125
– – ﹤0.01% 1533
2020
Q1 		$1K Buy
+125
New +$631 ﹤0.01% 1423

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's CTSO Position: Q4 2021 in Review

Lindbrook Capital sold out of Cytosorbents Corp (CTSO) in Q4 2021, closing a stake of 125 shares — an estimated $1K sold.

Lindbrook Capital first reported a position in CTSO in Q1 2020 and held it in 7 quarters. The position peaked at $1K in Q3 2021. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.

  • Lindbrook Capital reported no remaining Cytosorbents Corp position as of Q4 2021 after selling out during the quarter.
  • Lindbrook Capital sold 125 Cytosorbents Corp shares in Q4 2021, an estimated $1K.
  • Lindbrook Capital first reported a position in Cytosorbents Corp in Q1 2020 and held it in 7 quarters.
  • Lindbrook Capital's Cytosorbents Corp position peaked at $1K in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2021.

Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.